New drug shows improvement in survival of advanced thyroid cancer
In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free sur...
Author: mdanderson
Added: 02/11/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Oral Cancer | Study | Texas University | Thyroid | Thyroid Cancer